Metformin Vitabalans

Metformin Hydrochloride, the active ingredient in Metformin Vitabalans, is a biguanide presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑glucose control. GNH USA supplies Metformin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Vitabalans is a biguanide indicated for conditions where glucose regulation is impaired. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Prediabetes (impaired glucose tolerance): reduces the risk of progression to overt diabetes. - Polycystic ovary syndrome (off‑label): helps improve insulin resistance and menstrual regularity.

Metformin Vitabalans may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, especially during treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient after dosing. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe hypoglycaemia: usually when combined with insulin or secretagogues. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Allergic reactions: rash, pruritus, or angio‑edema. - Pancreatitis: inflammation of the pancreas. - Electrolyte disturbances: especially in renal impairment.

Metformin Vitabalans requires careful monitoring in several clinical situations. - Renal function: avoid or adjust dose in patients with impaired creatinine clearance. - Hepatic disease: use with caution; monitor liver enzymes. - Lactic acidosis risk: discontinue before surgeries or iodinated contrast studies. - Pregnancy and lactation: assess risk‑benefit; use only if clearly needed. - Vitamin B12 monitoring: check levels periodically during long‑term therapy. - Store at ambient temperature (below 25°C): keep in the original container, protect from moisture and light.

Metformin Vitabalans can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast media (radiographic): may precipitate lactic acidosis; withhold metformin before and after the procedure. - Cimetidine: can increase metformin plasma concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may affect renal function, requiring dose adjustment. - Diuretics: can lead to dehydration and reduced renal clearance of metformin. - Alcohol: excessive intake increases lactic acidosis risk. - Beta‑blockers: may mask hypoglycaemia symptoms when combined with insulin secretagogues.